Confocal Laser Endomicroscopy for the Morphometric Evaluation of Microvessels in Human Colorectal Cancer Using Targeted Anti-CD31 Antibodies by Cârţână, Tatiana et al.
 
Confocal Laser Endomicroscopy for the Morphometric Evaluation of
Microvessels in Human Colorectal Cancer Using Targeted Anti-
CD31 Antibodies
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Cârân, Tatiana, Adrian Sftoiu, Lucian Gheorghe Gruionu, Dan
Ionu Gheonea, Daniel Pirici, Claudia Valentina Georgescu,
Adriana Ciocâlteu, and Gabriel Gruionu. 2012. Confocal laser
endomicroscopy for the morphometric evaluation of microvessels
in human colorectal cancer using targeted anti-CD31 antibodies.
PLoS ONE 7(12): e52815.
Published Version doi:10.1371/journal.pone.0052815
Accessed February 19, 2015 11:57:48 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11181208
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAConfocal Laser Endomicroscopy for the Morphometric
Evaluation of Microvessels in Human Colorectal Cancer
Using Targeted Anti-CD31 Antibodies
Tatiana Ca ˆrt ¸a ˆna ˘
1, Adrian Sa ˘ftoiu
1*, Lucian Gheorghe Gruionu
1,2, Dan Ionut ¸ Gheonea
1, Daniel Pirici
3,
Claudia Valentina Georgescu
4, Adriana Cioca ˆlteu
1, Gabriel Gruionu
1,5
1Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, Craiova, Romania, 2Department of Mechanical Engineering,
University of Craiova, Craiova, Romania, 3Department of Histology, University of Medicine and Pharmacy of Craiova, Craiova, Romania, 4Department of Pathology,
Emergency County Hospital, Craiova, Romania, 5Steele Laboratory of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard
Medical School, Boston, Massachusetts, United States of America
Abstract
Introduction: Numerous anti-angiogenic agents are currently developed to limit tumor growth and metastasis. While these
drugs offer hope for cancer patients, their transient effect on tumor vasculature is difficult to assess in clinical settings.
Confocal laser endomicroscopy (CLE) is a novel endoscopic imaging technology that enables histological examination of the
gastrointestinal mucosa. The aim of the present study was to evaluate the feasibility of using CLE to image the vascular
network in fresh biopsies of human colorectal tissue. For this purpose we have imaged normal and malignant biopsy tissue
samples and compared the vascular network parameters obtained with CLE with established histopathology techniques.
Materials and Methods: Fresh non-fixed biopsy samples of both normal and malignant colorectal mucosa were stained
with fluorescently labeled anti-CD31 antibodies and imaged by CLE using a dedicated endomicroscopy system.
Corresponding biopsy samples underwent immunohistochemical staining for CD31, assessing the microvessel density
(MVD) and vascular areas for comparison with CLE data, which were measured offline using specific software.
Results: The vessels were imaged by CLE in both normal and tumor samples. The average diameter of normal vessels was
8.560.9 mm whereas in tumor samples it was 13.560.7 mm (p=0.0049). Vascular density was 188.7624.9 vessels/mm
2 in
the normal tissue vs. 242.4616.1 vessels/mm
2 in the colorectal cancer samples (p=0.1201). In the immunohistochemistry
samples, the MVD was 211.2642.9/mm
2 and 351.3639.6/mm
2 for normal and malignant mucosa, respectively. The vascular
area was 2.960.5% of total tissue area for the normal mucosa and 8.562.1% for primary colorectal cancer tissue.
Conclusion: Selective imaging of blood vessels with CLE is feasible in normal and tumor colorectal tissue by using
fluorescently labeled antibodies targeted against an endothelial marker. The method could be translated into the clinical
setting for monitoring of anti-angiogenic therapy.
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Introduction
Anti-angiogenic therapy has recently raised increasing interest
due to the possible implications related to targeted treatment and
prognosis stratification for a variety of solid tumors [1].
Nonetheless, the advent of new anti-angiogenic agents into the
oncological clinical practice has generated the need for enhanced
imaging methods for evaluation of the microvascular network
during treatment.
Angiogenesis has been traditionally evaluated by measuring the
microvessel density (MVD) on fixed tissue immunostained for a
variety of endothelial markers including factor VIII, CD31, CD34
[2] and previous studies have identified microvascular density
(MVD) as a potential prognosis factor for a number of solid
tumors. CD31, also known as platelet endothelial cell adhesion
molecule-1 (PECAM-1) is a pan-endothelial marker for both small
and large vessels [2]. Among its many functions CD31 has also
been related to the growth and metastatic spread of tumors, being
involved in the processes of angiogenesis and vascular permeability
[3].
Still, using immunohistochemistry and MVD to estimate
angiogenesis in the context of clinical trials has brought up
some ethical and practical concerns related to repeated
harvesting of biopsies from patients [4]. Functional imaging of
tumor vascularity is a promising alternative but most of the
clinically available imaging techniques do not have the
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Recently, confocal laser endomicroscopy (CLE) was developed
for the real-time in vivo histological analysis of the gut mucosa.
High-resolution optical sections in the horizontal plane of the
targeted tissue display cellular and subcellular details during
ongoing endoscopy [6]. A variety of clinical applications of the
technique have already been described in lesions of both the
upper and lower gastrointestinal tract, with particular interest
on neoplasia, where CLE generates real-time histological
diagnosis and targeted biopsies of relevant areas for a higher
diagnostic yield than random biopsies [7,8,9,10,11,12]. In
colorectal lesions, CLE has shown high accuracy in detecting
intraepithelial neoplasia based on the pattern of the vascular
network and crypt architecture [7].
Currently approved contrast agents for clinical endomicroscopy
examinations include dyes with unspecific staining properties such
as fluorescein, acriflavine or cresyl violet [13]. However, recent
studies have been performed on animal models and human tissue
samples using fluorescently labeled antibodies that enabled specific
endomicroscopic imaging of epidermal growth factor receptor
(EGFR) and vascular endothelial growth factor (VEGF)
[14,15,16]. By using fluorescein isothiocyanate-labeled antibodies,
CLE was able to differentiate expression levels of EGFR in murine
xenograft tumors and allowed distinction of human neoplastic and
non-neoplastic colorectal tissue based on their EGFR expression
patterns [14]. The same group proved that molecular imaging of
VEGF is feasible in different rodent models of gastrointestinal
cancers. Differences between the fluorescent strength of the VEGF
signal of normal and malignant human tissue specimens were also
demonstrated [15]. Molecular imaging of EGFR and survivin, an
apoptosis inhibitory protein, was also achieved with the probe-
based CLE system in esophageal and gastric mucosa of porcine
models [16].
The aim of the present study was to evaluate the feasibility of
the CLE system for imaging the vascular network of the human
colorectal tissue samples of both normal and malignant mucosa
using fluorescently labeled anti-CD31 antibodies. Since currently
there are no CD-31 markers approved for human use, we have
used the CLE imaging technique on fresh non-fixed human biopsy
samples stained with anti-CD31 antibodies to test the hypothesis
that the CLE system offers appropriate resolution for imaging the
tumor vasculature and collecting vascular parameters similar to
the currently accepted histopathology techniques.
Materials and Methods
Patients
The present feasibility study was performed on endoscopic
biopsies obtained from four patients with advanced colorectal
adenocarcinomas, which were diagnosed during routine colo-
noscopy procedures. The patients were subjected to conven-
tional biopsy forceps sampling of paired areas of the normal
colonic mucosa (taken at least 10 cm from the tumor) and of
the colorectal mass. The study was approved by the Ethics
Committee of the University of Medicine and Pharmacy of
Craiova. All patients provided their written informed consent
after receiving a standard form for biopsy collection via
colonoscopy which stated that the biopsy samples were further
analyzed by immunohistochemical techniques and used for
research purposes. Biopsies were analyzed according to a
common staining protocol (below) for conventional histopathol-
ogy examination and by CLE examinations after staining with
specific antibodies.
CLE Immunostaining Protocol
One paired sample of fresh human biopsies of about 2–3 mm in
diameter was harvested during lower endoscopic procedures from
both normal and neoplastic colorectal mucosa of each patient and
immersed in physiological saline. The fresh biopsies were
incubated in the dark with a monoclonal mouse antibody (IgG1,
clone MEM-05, 1:10 dilution) directed against human CD31/
PECAM-1 (Exbio, Prague, Czech Republic) and labeled with
Alexa-Fluor 488 for 1 hour at 37uC, and rinsed with physiological
saline to remove any unbound reagent. Samples were placed on
glass slides and immediately imaged by CLE for vascular
structures. For optimizing the technique, different antibody
dilutions in 1% bovine serum albumin in PBS (BSA, Sigma-
Aldrich, St. Louis, Missouri, USA), ranging from 1:5 to 1:30, were
previously tested on fresh, non-fixed tissue samples and imaged
with an automated fluorescence microscope (Nikon 90i, Tokyo,
Japan). A time frame of approximately 60 minutes that allows
binding of the antibodies to their target and sample imaging
without tissue degradation was also established.
CLE Imaging
In this study, we used the CLE system which integrates a
miniature confocal microscope into the distal tip of a conventional
flexible endoscope (EC-3870 CIFK, Pentax, Tokyo, Japan). The
confocal lens at the distal tip is slightly advanced outside the
endoscope, allowing targeted scanning of the structures. During
the scanning, the laser delivers an excitation wavelength of
488 nm with a maximum laser power output of #1 mW at the
surface of the tissue which is controlled by the user during the
examination for optimal imaging contrast. The maximum depth of
imaging is 250 mm from the surface of the mucosa. The resulting
optical sections have a lateral resolution of 0.7 mm for a 7 mm thick
slice (z-axis) and a field of view of 4756475 mm.
The endomicroscope was mounted onto a fixed frame and the
biopsies were placed on histology glass slides, in direct and gentle
contact with the distal tip of the confocal laser endomicroscope.
The images were captured by pressing a foot switch pedal and
were digitally stored on the system’s hard drive as grey-scale
images (150–250 for each biopsy sample) for later download and
processing.
Vascular Network Measurements
We analyzed the CLE images by using Image J (National
Institutes of Health, Bethesda, Maryland, USA). Five images with
the strongest fluorescent signal and a good display of the vascular
network were chosen from each tissue sample for the analysis of
the vascular structures. For a more clear distinction of the vessels, a
color overlay was added to match the fluorescent contrast agent
(Figure 1). The straight line tool was used to manually measure the
diameter of each vascular segment between either two branching
points or a branching point and a loose end. Each vascular
segment was labeled and counted for the vascular density. The
results were exported in an Excel file and reported as the mean 6
standard error (SE) for each chosen image and individual case.
The measurements for diameter and vascular density were
performed independently by two different operators who were
blinded to each other’s findings and to the pathology report. The
results were reported as the mean of the two measurements.
Conventional Immunohistochemical Staining
Correspondent biopsy samples from colorectal tumors were
placed in 4% neutral buffered formalin for fixation and paraffin
embedding. Conventional pathology diagnosis was based on H&E
CLE for Endothelial Imaging
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was done according to the manufacturer’s indications (Dako,
Glostrup, Denmark). Briefly, after citrate buffer-mediated antigen
retrieval, sections were cooled to room temperature and incubated
for 30 minutes in 1% hydrogen peroxide. The sections were next
washed in PBS, followed by a blocking step of 30 minutes in 1%
skim milk. The anti-CD31 primary antibody (IgG1, clone JC70A,
mouse anti-human, Dako, Glostrup, Denmark) was added diluted
as 1:100, and the slides were incubated overnight at 4uC. Next
day, the slides were washed, the signal was amplified utilizing a
peroxidase–EnVision polymer-based species-specific secondary
detection system (Dako, Glostrup, Denmark), and then detected
with 3,39-diaminobenzidine (DAB, Dako,Glostrup, Denmark). All
washing steps were done in 0.1 M PBS, pH 7.2, and the primary
antibody was diluted in PBS with 1% BSA. All incubation times
were kept constant for all the slides included in the present study.
Finally, the slides were coversliped after the Hematoxylin staining.
Microvessel Density (MVD) Measurement
All microscopic image analysis was performed with a Nikon
Eclipse 55i microscope coupled to a 5 Mp color CCD camera
(Nikon, Tokyo, Japan) and an image-analysis station based on the
Image ProPlus AMS7 software (Media Cybernetics, Bethesda,
Maryland, USA). In order to assess the MVDs on the CD-31
Figure 1. Ex-vivo CLE imaging with AF488-anti-CD31-antibodies. In the normal mucosa, the vessels are organized in a hexagonal network (A);
the corresponding area in the tumor shows more dilated, irregularly shaped vessels, with varying diameters along their length (B); the same optical
sections are shown with added color overlay (C, D). *Scale bar is 50 mm.
doi:10.1371/journal.pone.0052815.g001
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hotspot method was utilized as previously described [17]. In the
tumor tissue, the operator used the 10x and 20x objectives to
identify the ‘‘hot-spots’’, i.e. the areas with the highest vascular
density. In these areas three to four random images were captured
under the 40x objective. In the normal tissue three to four random
images were captured under the 40x objective, excluding areas
abounding in non-mucosal/inflammatory cells.
The vascular-related CD31 staining areas (region of interest,
ROI) were marked directly onto the images by two independent
operators and included vessels with an identifiable lumen, as well
as single or clusters of non-luminal endothelial cells. Inflammatory
cells taking up the stain (i.e. plasmocytes) and red blood cells with
no staining around them were excluded. A macro command in
Image ProPlus was developed to count the number and measure
ROI areas in each image, and the data was reported in an Excel
file as MVD and vascular area, respectively. For comparison with
other published data, both the CLE vessel density and the MVD
determined from immunohistochemistry were normalized to a
mm
2 area.
Statistical Analysis
Statistical analysis was performed in Microsoft Office ExcelH
(Microsoft, Redmond, Washington, USA). The results were
expressed as averages 6 SE of the mean. For the morphometric
evaluation, comparison was made between normal and tumor
vasculature. To determine the significance of the differences
between the vascular measurements, a two-tailed t-test was
performed with statistical significance achieved at a p value ,0.05.
Results
Microvascular CLE Patterns
A specific fluorescent signal was identified with the CLE scope
in all biopsies in normal and neoplastic tissue samples. The vessels
in normal biopsies formed a hexagonal pattern with homogeneous
distribution of diameters characteristic of a normal mucosa as
outlined by the selective CD31 staining (Figure 1A and 1C). In
tumor samples the vessels appeared dilated and irregular in shape
compared to the normal mucosa, with variable diameters along
their length (Figure 1B and 1D).
Morphometric Analysis of Microvessels
Vessels were counted and their diameters measured between
two vascular intersections, for the entire field of view (Figure 2).
The average vessel diameter in tumor samples was 13.560.7 mm,
significantly higher than the vessel diameter in normal colorectal
mucosa (8.560.9 mm, p=0.0049). The vascular density was
242.4616.1 vessels/mm
2 in tumor tissue samples and
188.7624.9 vessels/mm
2 in the normal tissue (p=0.1201).
Immunohistochemistry
Corresponding biopsies from adjacent tissue to CLE biopsies
were prepared for the immunohistochemical study with an anti-
CD31 antibody in both normal and colorectal cancer samples. In
the normal mucosa, the MVD was 211.2642.9 while in the
malignant tissue it was 351.3639.6/mm
2 (p=0.0637). The
vascular area, calculated as the percentage of ROI over the entire
image area, was higher in the tumor samples (8.562.1%)
compared to the normal colorectal tissue (2.960.5%), p=0.0735
(Figure 3). The summary of the vascular parameters measured in
the primary colorectal cancer and the corresponding normal
mucosa, from immunohistochemistry and CLE samples, is
presented in Table 1.
Discussion
Since the initial hypothesis of the role of angiogenesis in tumor
progression formulated by Judah Folkman four decades ago [18],
our fundamental understanding of this process has advanced and
Figure 2. Vascular measurements on CLE images. A vessel was counted and its diameter was measured for each vascular segment between
two branching points or a branching point and a loose end. Vascular density was reported per mm
2. Both vessel diameter and vascular density were
increased in the tumor tissue (B) compared to the normal mucosa (A). *Scale bar is 50 mm.
doi:10.1371/journal.pone.0052815.g002
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under clinical investigation [4]. Nonetheless, there are still many
concerns related to selection of the optimal dosage and timing,
prediction and monitoring of the patients’ response that limit the
use of anti-angiogenic therapy for oncology patients. In the present
study, we have used a CLE endoscope to image the vascular
pattern from fresh biopsies of normal and malignant colorectal
tissue and compared the results with traditional histopathologic
techniques.
To our knowledge, this is the first report on histological imaging
of vessels obtained with CLE by applying fluorescently labeled
antibodies directed against an endothelial marker (CD31). This
method generates similar results as the traditional immunohisto-
chemistry, but on fresh non-fixed tissue. Thus, any processing
artifact of the biopsies is avoided and imaging of the tissue is
performed in its natural state within a short time after biopsy
collection which considerably speeds up the diagnosis process. We
chose as a molecular target a pan-endothelial marker for labeling
of both normal and tumor blood vessels in order to obtain a
Figure 3. Immunohistochemical staining for CD31. Bright field images of the formalin fixed and paraffin embedded biopsies of normal and
primary colonic cancer stained for CD31 showing: blood vessels regularly distributed between the intestinal glands in the normal colonic mucosa (A);
multiple irregular vessels in the intratumoral stroma, in malignant samples (B); the same images with vascular areas marked for automated counting
(C, D).*Scale bar is 50 mm.
doi:10.1371/journal.pone.0052815.g003
Table 1. The vascular parameters obtained with CLE and immunohistochemistry in normal mucosa and colorectal cancer.
CLE (Mean±SE) Immunohistochemistry (Mean±SE)
Vessel diameter (mm) Vascular density (vessels/mm
2) MVD (vessels/mm
2) Vascular area (%)
Normal mucosa 8.560.9 188.7624.9 211.2642.9 2.960.5
Tumor 13.560.7 242.44616.1 351.3639.6 8.562.1
P-value 0.0049 0.1201 0.0637 0.0735
doi:10.1371/journal.pone.0052815.t001
CLE for Endothelial Imaging
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confocal optical sections showed differences between the vascular
patterns of normal and tumoral tissue. The malignant blood
vessels looked more dilated and tortuous compared to the regular
appearance of the normal vessels. It is a known fact that tumor
blood vessels are abnormal in their structure and function. This
was also shown by previous CLE classifications of neoplasia
following intravenous administration of fluorescein [7,19]. How-
ever this unspecific contrast agent tends to diffuse excessively into
the interstitial space due to increased permeability of the
pathologic vessels. As a result vascular borders are concealed
and their quantitative assessments becomes a challenge. In the
present approach, selective staining of vessels with an endothelial
marker has overcome this drawback.
With traditional immunohistochemical staining protocols the
tissue is typically sectioned in 4 mm thick slices which capture only
crossections of blood vessels at different angles. The proposed CLE
imaging method allows the display of entire vascular segments in
the same image. We were thus able to perform a morphometric
analysis on the optical confocal sections that came to validate the
qualitative differences already noted between the two vascular
beds. We found that tumor blood vessels have a significantly
greater average diameter than normal vessels (13.5 mm vs. 8.5 mm,
p=0.0049). In tissue samples from the colorectal cancer regions,
there was a 28.5% increase in vascular density compared to the
normal mucosa (242.4 vs. 188.7 vessels/mm
2). Only one param-
eter (vessel diameter) reached statistical significance in our study.
This could be explained by the small number of samples included
in our analysis. Future studies on a larger patient sample are
needed to confirm the findings beyond the present proof of
concept study.
The vascular parameters obtained with CLE are comparable
with the traditional methods and the published literature
[20,21,22]. The CLE results were validated by a classical
immunohistochemical technique which revealed a positive signal
for CD31 in both control and malignant samples. There was a
similar trend for increased MVD and vascular area in the samples
from the primary colorectal cancer compared to the normal
mucosa. Previously reported results on human colorectal vascular
morphometry vary among different studies due to differences in
methodology and processing techniques [20,21] but overall agree
with our results. In a study of the normal colonic microcirculation
on corrosion casting a diameter of 10 mm was reported for
precapillary arterioles in the mucous plexus [22]. By immunohis-
tochemical staining for CD34, also a pan-endothelial marker, the
mean vascular diameter for the normal colonic mucosa was
7.661.5 mm [21].
Our proof of concept findings demonstrate the feasibility of the
technique and could lay the ground for further research. While
this study used a pan-endothelial marker, future similar studies
could target other markers for the proliferating endothelium, such
as VEGFR2, which are relevant to tumor-induced angiogenesis.
The short time frame (one hour between collecting the biopsy and
imaging the CD31 marked tissue with CLE) and the use of a
standard staining protocol for fresh biopsies samples makes the
targeted CLE technique compatible with the clinical setting
provided that the equipment is available.
Our present results and prior reports on similar approaches
suggest that CLE has the potential for imaging neovascularization
in situ during live procedures. Since anti-angiogenic drugs tend to
normalize tumor vasculature for a short period of time of several
days to a few weeks it is desirable to find a way to monitor the
vascular network remodeling during this window of opportunity,
when the tumor also becomes more responsive to chemotherapy
and/or radiotherapy [23]. CLE, alone or in combination with
other molecular and cellular biomarkers, could be used for this
particular purpose, pending on the discovery of novel targeted
contrast agents. As mentioned, recent reports show good
preliminary data with fluorescently labeled antibodies targeting
EGFR or VEGF, suggesting the feasibility of such immunoendo-
scopy approaches. Nevertheless, development of human use
targeted pan-endothelial markers such as fluorescently labeled
anti-CD31 antibodies might represent a valid real-time alternative
to the conventional MVD analysis of fixed biopsy samples.
In conclusion, we showed that selective imaging of blood vessels
is possible with CLE by using fluorescently labeled antibodies
targeting a specific endothelial marker in fresh biopsies. Offline
morphometric analysis of the confocal images with additional
processing software demonstrated significantly different patterns
between normal and malignant vascular networks. In the future
this approach could be used for a better selection of patients for
clinical trials and a more sensible monitoring of the vascular effects
of anti-angiogenic agents in individually tailored therapies.
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